On the other hand, an almost significant reduction in heart failure relapses managed not in a hospital setting was observed and defined as the presence of signs and symptoms of heart failure treated with the implementation of diuretic therapy maintained for at least 28 days: the sacubitril/valsartan group presented 39 events (1.4%) vs. 57 (2.0%) of the ramipril group [HR 0.68 (0.45–1.03), P = 0.07].
← all excerpts
Does sacubitril/valsartan work in acute myocardial infarction? The PARADISE-AMI study.
1
—
—